| | | | | | | | | Sponsored | | Routine quality control plays a critical role in molecular women's health testing. Explore third-party, whole-organism NATtrol™ controls for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium, and more. Available in ready-to-use liquid and swab formats. |
|
|
| | |
| |
| | |
|
|
| | | | | | Every lab has its personalities, pressure points, and moments of unexpected teamwork. If your lab were a TV show, which would it most resemble? Take our poll and see which show gets your vote. |
|
|
| | The College of American Pathologists (CAP) recently published an article highlighting the benefits of point-of-care testing for sexually transmitted infections (STIs). It contains important information for patients, clinicians, and lab professionals. |
|
|
|
| |
| | |
|
|
| | | | | | Sponsored | | Upgrade your cobas® 6800/8800 systems to Software 2.0. Experience lightning-fast performance, improved user experience, and intelligent scheduling that eliminates manual sorting. Save time and costs with flexible, customizable QC intervals. Evolve your lab. |
|
|
| | |
| |
| | |
|
|
| | | | | | In Coaching Corner, Patty Eschliman tackles real-world questions about compensation, leadership, workplace relationships, laboratory technology, accountability, and the changing workforce. Get practical advice for navigating these challenges and growing your career. |
|
|
|
| |
| | |
|
|
| | | | | | Thermo Fisher Scientific has launched Invitrogen SuperScript V Reverse Transcriptase, a next-generation engineered enzyme designed to make converting RNA to cDNA faster, easier, and more flexible. |
|
|
|
| |
| | |
|
|
| | | | | | Sponsored | | Mass spectrometry is revolutionizing healthcare by providing more precise and reliable diagnostics. This innovative technology accurately measures complex biological samples, offering valuable insights to healthcare professionals. By improving diagnostic test accuracy, mass spectrometry supports better-informed decisions and more tailored, effective patient care. |
|
|
| | |
| |
| | |
|
|
| | | | | | The Food and Drug Administration’s, Center for Biologics Evaluation and Research, Office of Blood Research and Review has announced an upcoming roundtable to help develop strategies aimed at improving the blood manufacturing supply chain. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
